MaxCyte, Inc. (MXCT) vs Quanterix Corporation (QTRX)
MaxCyte, Inc. and Quanterix Corporation are both Medical Devices companies. Quanterix Corporation is the larger, with a market value of $150.4M against $122.8M — 1.2× the size. Quanterix Corporation grew revenue faster over the last twelve months: 22.0% against −13.2%. Quanterix Corporation has the higher net margin (−80.3% vs −114.8%) and the lower return on invested capital (−66.5% vs −49.2%). Across the 17 metrics below, Quanterix Corporation leads on 9 and MaxCyte, Inc. on 8.
Valuation
Profitability
| Metric | MXCT | QTRX | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 44.56% | 56.01% |
| Operating margin | (134.59%) | (99.65%) | (15.03%) |
| Net margin | (114.77%) | (80.25%) | (20.40%) |
| Free cash flow margin | (76.14%) | (53.24%) | (7.24%) |
| Return on equity | (20.39%) | (46.48%) | (15.32%) |
| Return on assets | (17.62%) | (35.41%) | (19.72%) |
| Return on invested capital | (49.23%) | (66.50%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack